EICHOR
● Recruiting
A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)
Condition: Myeloma Multiple · Sponsor: Biocad
About this study
The aim of the study is to assess the efficacy and safety of the BCD-248 in combination with daratumumab versus the combination of daratumumab, pomalidomide, and dexamethasone in the treatment of relapsed or refractory multiple myeloma. The study will be conducted in a population of male and female subjects aged 18 years and older, with confirmed symptomatic multiple myeloma with measurable disease, who have received one prior line of therapy that included a proteasome inhibitor and lenalidomide and were refractory to lenalidomide, or who have received two or three prior lines of therapy that included a proteasome inhibitor and lenalidomide, with disease progression during or after the last line of therapy.
This description comes directly from the study's public registry record.
Talk to the study team
Evgeniia Mikhailova · +79110812368 · mikhailova@biocad.ru
Always discuss trial participation with your own doctor first.
Locations (16)
| SI "Republican Scientific and Practical Center for Radiation Medicine and Human Ecology" | Homyel, Belarus | Recruiting |
| SBHI "Chelyabinsk regional clinical hospital" | Chelyabinsk, Russia | Recruiting |
| SBHI "Regional oncological dispensary" | Irkutsk, Russia | Recruiting |
| SAHI "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal" | Kazan', Russia | Recruiting |
| Regional Government-Owned Publicly Funded Healthcare Institution "Regional Clinical Hospital" | Krasnoyarsk, Russia | Recruiting |
| Branch Office of Hadassah Medical Ltd. | Moscow, Russia | Recruiting |
| BHI of the Omsk region "Clinical Oncological Dispensary" | Omsk, Russia | Recruiting |
| St. Petersburg State Healthcare Institution "City Hospital No. 15" | Saint Petersburg, Russia | Recruiting |
| FSBI "National Medical Research Center named after V.A. Almazov" of the Ministry of Health of the Russian Federation | Saint Petersburg, Russia | Recruiting |
| FSBI "Russian Research Institute of Hematology and Transfusiology" of the Federal Medical and Biological Agency | Saint Petersburg, Russia | Recruiting |
| SBHI "Leningrad Regional Clinical Hospital" | Saint Petersburg, Russia | Recruiting |
| FSBEI of Higher Education "Samara State Medical University" of the Ministry of Health of the Russian Federation | Samara, Russia | Recruiting |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07742215